PC3I News
The University of Pennsylvania (Penn) Telehealth Research Center of Excellence (Penn TRACE), based at the Penn Center for Cancer Care Innovation (PC3I) at the Abramson Cancer Center, is one of four National Cancer Institute (NCI) Telehealth Research Centers of Excellence dedicated to advancing the nation’s telehealth research agenda focused on improving cancer-related care and outcomes. With support from the White House Cancer Moonshot, Penn TRACE applies insights from communication science and behavioral economics to design and test innovative telehealth approaches to improve effectiveness and equity across the cancer care continuum, with an emphasis on advancing health equity and addressing the digital divide.
Three PC3I Innovation Faculty will lead the center as principal investigators: Katharine Rendle, PhD, MSW, MPH; Anil Vachani, MD, MS; and Justin Bekelman, MD, Director of PC3I.
Read the full Penn Medicine press release as well as the National Cancer Institute press release.
Learn more about Penn TRACE.
Related News
PC3I News
PC3I Faculty Roger Kim Receives K08 Career Development Award from National Cancer Institute
09.21.2023
PC3I Faculty Roger Kim, MD, MSCE has been awarded a K08 Mentored Clinical Scientist Career Development Award from the National Cancer Institute, which provides support and mentorship to clinician scientists for research and career development activities.
PC3I News
Penn Center for Cancer Care Innovation 2022-2023 Impact Report
09.11.2023
PC3I is pleased to share our 2022-2023 Impact Report, which shares highlights from our work over the past year to create, test, and scale solutions to some of the most intractable problems in cancer care delivery.
PC3I News
Administrative Payment Tasks Increase Likelihood of Treatment Delays and Nonadherence
08.30.2023
A study led by PC3I Faculty Meredith Doherty, PhD, LCSW showed that patients with cancer and survivors of cancer who engaged in administrative payment tasks were more likely to experience treatment delays or treatment nonadherence.